Advertisement

Topics

Tesaro's Zejula quickly gaining in PARP market

05:12 EDT 10 Aug 2017 | BioPharmaDive

The launch of Zejula is off to a strong start in the U.S., while commercialization in the EU is planned for later this year. 

Original Article: Tesaro's Zejula quickly gaining in PARP market

NEXT ARTICLE

More From BioPortfolio on "Tesaro's Zejula quickly gaining in PARP market"

Quick Search
Advertisement